Abstract
The 2017 European Leukemianet Genetic Risk Classification Performs Poorly in Older Patients with Acute Myeloid Leukemia (AML) and Should be Refined to Identify Patients Requiring Additional or Alternative Treatment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have